Home > Income Statement > INDO US BIOTECH

INDO US BIOTECH
Consolidated Net Profit

    Back to Income Statement
INDO US BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

INDO US BIOTECH Last 5 Year Consolidated Net Profit History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021

What is the latest Consolidated Net Profit of INDO US BIOTECH ?

The latest Consolidated Net Profit ratio of INDO US BIOTECH is ₹8.11 based on Mar2025 Standalone results.
Year Consolidated Net Profit
Mar2025₹8.11
Mar2024₹4.12
Mar2023₹3.61
Mar2022₹2.86
Mar2021₹3.50

How is Consolidated Net Profit of INDO US BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹8.11
0
Mar2024 ₹4.12
0
Mar2023 ₹3.61
0
Mar2022 ₹2.86
0
Mar2021 ₹3.50 -

Compare Consolidated Net Profit of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹297.3 Cr 2.5% 25% -31.9% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,411.4 Cr -1.6% 2.6% -6.1% Stock Analytics
KAVERI SEED COMPANY ₹4,241.2 Cr -2.1% 0.8% -16.4% Stock Analytics
VENKYS (INDIA) ₹1,951.1 Cr -2.5% -6.3% -17.4% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹956.9 Cr -0.8% -2% -34.8% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹385.3 Cr -1.9% -4.8% -3.4% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

2.5%

25%

-31.9%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses